Bird & Bird provide a complete service to its clients in the healthcare and life sciences sectors. It advises on IP, regulatory, transactional corporate, EU and competition, data protection and dispute resolution matters. Massimiliano Mostardini and Giovanni Galimberti head the practice, both focusing on IP matters affecting the sector including trademarks, copyright and unfair competition. Within the practice, Antonella De Gregori utilises her specialist knowledge in the pharmaceutical sector, and Claudia Ricciardi drafts and negotiates patent/know how licences and assignment agreements. Evelina Marchesoni and Mauro Turrini are also of note. In May 2023, Elisabetta Bandera and Rita Tardiolo were made partners.

The multidisciplinary practice at BonelliErede assists its clients in the healthcare and life sciences sectors in all manner of matters. The firm has deep knowledge of the pharmaceutical and biomedical markets, advising on matters involving EU and competition law, litigation, administrative issues, M&A, IP and tax. Other notable members within the practice include managing partner Andrea Carta Mantiglia, who specialises in M&A, litigation and international arbitration within the sector, and IP specialist Giovanni Guglielmetti. Sarah Lembo‘s broad expertise includes a focus on EU and anti-trust law. Vincenzo Salvatore left the practice in March 2024.

DLA Piper’s healthcare and life sciences practice spans the sector, with experience in corporate, regulatory, public procurement, privacy, IP, competition and litigation. The firm advises major players in the industry, including national and multinational pharmaceutical corporations, on domestic and cross-border matters. Roberto Valenti is the head of the department at the firm; he advises on IP litigation and commercial matters in the life science sectors, with particular expertise on matters involving medical devices. Marco de Morpurgo focuses on the EU and national regulation of pharmaceuticals, biotech and medical devices. Raffaella Quintana (compliance and criminal law) and Gualtiero Dragotti (IP) can bring their considerable talents to this sector.

Herbert Smith Freehills LLP assists clients on matters across the healthcare and life sciences spectrum, such as IP disputes, regulation and compliance issues, white-collar crime investigations, clinical trials, privacy issues and financings. Managing partner Laura Orlando leads the practice alongside assisting clients in IP-related healthcare and life sciences matters, with a particular focus on patent litigation in the pharmaceutical, biotech and chemical sectors. Within the team, Sara Balice assists clients in matters concerning patents, trademarks, copyright, design, unfair competition and trade secrets. In February 2023, Augusto Santoro joined the firm from Simmons & Simmons.

Hogan Lovells International LLP combines practices to ensure all matters arising in the healthcare and life sciences industries can be dealt with, including M&A, commercial, regulatory, product liability, IP, compliance and litigation. The firm also maintains a good relationship with the Italian health authorities. The practice is led by Christian Di Mauro, who has a focus on product liability, safety, compliance and regulation. Within the healthcare and life sciences department, Giuseppe Aminzade is highly knowledgeable in pharmaceutical law, medical liability and administrative law affecting the industry. Chiara Perolari is also noted for her assistance in regulatory matters and clinical trial support.

Portolano Cavallo advises major healthcare and life sciences clients on transactional/contractual, IP, compliance and regulatory, product liability and litigation matters. Luca Gambini and Elisa Stefanini lead the practice group. Gambini has a particular strength in M&A transactions relating to the life sciences sector, whilst Stefanini focuses on regulatory and compliance matters for pharma, biotech and med-tech clients. Andrea Gritti joined the firm from Gianni & Origoni in March 2023, with Gianpaolo Scandone following from Gatti Pavesi Bianchi Ludovici in June 2023. In July 2023, Enzo Marasà was promoted to partner.

ADVANT Nctm assists the full range of actors in the healthcare and life sciences sector, from manufacturers and pharmaceutical companies to regulators, investors and public-private partnerships. The firm draws talent from across departments to cater to each matter, be it IP, anti-trust or administrative. The two heads of the healthcare and life sciences practice are Lorena Possagno, who focuses on corporate and commercial assistance, and Paolo Gallarati, who specialises in international transactions and compliance in life sciences. In 2023, both Jacopo Arnaboldi and Giulio Uras were promoted to partner.

Studio Professionale Associato a Baker & McKenzie’s expertise stretches across the healthcare and life sciences sector with the ability to advise on regulatory, compliance, IP, clinical trials, disputes and administrative issues. The firm is experienced with the plethora of contentious issues that may affect its clients. Roberto Cursano leads the firm’s healthcare and life sciences practice. He frequently assists clients with regulations, contract law, pricing, clinical trial, public procurement and anti-bribery matters. Within the practice, Mario Cigno is noted for advising clients on regulatory matters, including public tender, clinical investigations and recalls.

Chiomenti maintains a dedicated multidisciplinary team for the healthcare and life sciences industry. It regularly advises on acquisitions and broader corporate matters in addition to areas such as tax planning, compliance and anti-trust. Its clients range from pharma manufacturers, research companies and producers of medical devices to companies that offer healthcare and hospital services. Luca Liistro leads the practice group whilst assisting clients on corporate and commercial matters. Filippo Brunetti advises on a range of corporate matters, pricing and market access together with compliance issues (he liaises with various authorities such as the Italian Pharmaceutical Agency. Corporate/M&A specialist Francesca Villa includes a number of pharma and medtech companies among her clients.

Dentons advises clients from all sides of the healthcare and life sciences sector, including public and private bodies. The firm leverages its multidisciplinary practice to draw the requisite expertise for each matter brought by a client, from corporate to administrative. The head of the practice is Luca Pocobelli, who is greatly experienced in assisting major domestic and international clients on corporate and M&A matters related to healthcare and life sciences. Within the practice, Ilaria Gobbato advises clients through public procurement procedures and project financing.

Gitti and Partners centres IP and regulatory work within its healthcare and life sciences practices. In addition, the firm functions as a one-stop-shop for its clients, assisting with corporate and M&A, commercial, data protection, administrative, employment and litigation matters. Its clients include domestic and international corporations with interests inside Italy. Paola Sangiovanni is the lead for life sciences with a focus on commercial, corporate and regulatory matters, including acquisitions, licence agreements and the drafting and negotiation of contracts. Flavio Monfrini  is a key team member, advising life sciences and new technology clients on corporate and commercial law and regulatory issues.

Orrick, Herrington & Sutcliffe provides a full coverage of the healthcare and life sciences sector, advising on competition, M&A, commercial agreements, regulatory, data protection, litigation and white-collar crime matters. The firm’s capabilities also include supporting domestic and international firms with cross-border matters. Jean-Paule Castagno is experienced in white-collar crime matters, including litigation and crisis management. Attilio Mazzilli assists clients through corporate and M&A - advising on major pharmaceutical transactions. Pietro Merlino left the practice for Legance - Avvocati Associati in November 2023.

Osborne Clarke assists clients from across the healthcare and life sciences sector on major and complex M&A deals as well as on competition law. The firm is also well-versed in supporting clients through IP, regulatory and compliance matters. Maria Grazia Medici is the head of the life sciences team at the firm and specialises in the regulation of pharmaceutical products, active substances and medical devices. Within the team, Giulia Verusio provides experience in corporate and commercial law as well as pharmaceutical litigation.

Pavia e Ansaldo has longstanding experience in the healthcare and life sciences sector, and it maintains active communication with globally significant regulatory bodies including the European Medicines Agency and the US Food and Drug Administration. The firm is expert in advising major pharmaceutical and biotechnology clients on IP litigation, regulatory, M&A, competition and data protection matters with an international element. Gian Paolo Di Santo leads the firm’s life sciences practice alongside his IP litigation, corporate and regulatory work for leading multinationals in the life sciences industry.

Trevisan & Cuonzo is noted for its expertise in litigation assistance connected to the pharmaceutical, biotech and medical devices sectors - all areas in which managing partner Gabriel Cuonzo is highly experienced. Donatella Capelli is well-versed in patent litigation and regulation, while Daniela Ampollini assists foreign and domestic clients in IP matters with a focus on the pharmaceutical and medical devices sectors. Luca Pellicciari supports clients through the regulatory aspects concerning pharmaceutical production and Federica Bocedi is also of note.

Franzosi Dal Negro Setti provides assistance at every point of the pharmaceutical product chain and other life sciences matters. The firm’s clients include multinational companies as well as smaller domestic clients. Francesco Setti is known for his mastery of pharmaceutical and healthcare law and regulations, while Stefano Giberti is very experienced in advising on the pharmaceutical and medical devices sectors, including on payback and administrative disputes. In addition, Francesca Libanori complements the practice with her deep knowledge of pharmaceutical regulation. In December 2023, Vincenzo Jandoli left the practice for Lexsential.

 

Gianni & Origoni assists its healthcare clients in the broad range of matters that arise in the sector, including acquisitions, licences, IP disputes, antitrust issues and labour matters. Its clients include pharmaceutical and biotech and medical device companies and public healthcare companies. Rosario Zaccà, the lead of the healthcare and life sciences practice, is well-versed in corporate and M&A, commercial, private equity and joint venture matters with a multi-jurisdictional element. In March 2023, Andrea Gritti departed the firm for Portolano Cavallo.

LCA Studio Legale maintains a wide focus of practice, with experience advising in pharmaceutical, biotech, medical devices, healthcare, clinical trials, regulatory, M&A and litigation matters. Agostino Migone de Amicis is one of the heads of the healthcare and life sciences practice at the firm and regularly advises on corporate and regulatory matters with a particular focus on clinical trials. Andrea Carreri, the other practice head, is also noted for his assistance in pharmaceutical matters.

Legance - Avvocati Associati assists foreign and domestic clients from across the sector, including hospitals, pharmaceutical and biotech companies. The firm maintains a strong expertise in the industry’s regulatory framework as well as matters involving corporate, IP, compliance, administrative and competition law. Giovanni Nardulli  is the firm’s head of practice and focuses his work on M&A matters, especially involving cross-border transactions. Pietro Merlino joined the firm in November 2023 from Orrick, Herrington & Sutcliffe.

LS CUBE Studio Legale maintains a focused practice in commercial, corporate and regulatory matters in life sciences. Paola La Licata has a wealth of experience in regulatory, compliance and commercial matters connected to the life sciences sector. Rosanna Sovani is noted for her market access expertise in the industry. Paolo Ricci focuses his life sciences practice on commercial, corporate and M&A matters. Massimiliano Marinozzi is also noted for his work in mass litigation.

Masotti Cassella is accustomed to advising clients in a range of sectors, including medical devices, biotech and pharmaceuticals. The firm also advises on research and development and clinical trial agreements. Luca Masotti co-heads the firm’s life sciences department where he utilises his experience on corporate and M&A matters, including those involving international transactions. Joint co-head Carlo Piatti, is advises on banking, commercial, corporate, public law and litigation matters.

PedersoliGattai maintains a dedicated specialist healthcare and life sciences group. It advises on corporate and regulatory matters that may be contentious or non-contentious. The firm serves clients from the pharmaceutical, biotechnology and medical devices sectors. Luca Saraceni, who is expert in advising a broad spectrum of clients on M&A transactions in the healthcare and life sciences industry, leads the practice alongside Sergio Fienga, who is experienced in administrative and regulatory matters.

Simmons & Simmons leverages its strength in IP matters on a domestic and international level in the healthcare and life sciences industry. The healthcare and life sciences practice is led by Stefania Bergia, who assists clients on domestic and international IP matters as well as competition and arbitration cases, and Giulio Enrico Sironi, who is experienced in contentious and non-contentious IP matters with an international element. The team has recently seen the arrival of European health and life sciences regulatory specialist Vincenzo Salvatore, who brings valuable expertise in EU life sciences regulation and compliance, advising clients on intricate matters related to pharmaceutical and medical products. Augusto Santoro left the firm in February 2023 for Herbert Smith Freehills LLP.